Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.040
Buy
RSI(14)
57.847
Neutral
STOCH(KDJ)(9,3,3)
75.822
Neutral
ATR(14)
0.136
High Vlolatility
CCI(14)
145.957
Buy
Williams %R
23.187
Buy
TRIX(12,20)
0.469
Sell
StochRSI(14)
60.153
Sell
Search
Helius Medical Technologies Inc
HSDTAdd to Watchlist
2.300USD
-0.090-3.77%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
133.49MMarket Cap
0.01P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Helius Medical Technologies Inc
Currency: USD Updated: 2026-05-15Key Insights
Helius Medical Technologies Inc's fundamentals are relatively healthy, with industry-average ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 147 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 3.50.In the medium term, the stock price is expected to trend up.Despite a good stock market performance over the past month, the company shows weak fundamentals and technicals, which don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Helius Medical Technologies Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Helius Medical Technologies Inc Highlights
StrengthsRisks
Solana Company, formerly Helius Medical Technologies, Inc., is a digital asset treasury dedicated to acquiring Solana (SOL), created in partnership with Pantera and Summer Capital. It is focused on maximizing SOL per share by leveraging capital markets opportunities and on chain activity. It offers public market investors optimal exposure to Solana’s secular growth. It has adopted a digital asset treasury strategy focused on accumulating SOL, the native digital asset of the Solana blockchain, leveraging capital markets raises that produce consistent on-chain yield generation. It will provide access to the Solana network. Solana DAT provides access to the blockchain market to a new kind of investor. As a global capital markets onramp, HSDT channels liquidity into the Solana ecosystem, strengthening network security and fueling on chain activity, creating a virtuous cycle that delivers value back to shareholders.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 834.32% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 6.02M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 6.02M.
Overvalued
The company’s latest PE is 0.01, at a high 3-year percentile range.
Institutional Buying
The latest institutional holdings are 16.40M shares, increasing 7.26% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 15.70K shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.42.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
3.500
Target Price
+46.44%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-15The current financial score of Helius Medical Technologies Inc is 5.64, ranking 193 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is stable, and its operating efficiency is low. Its latest quarterly revenue reached 3.62M, representing a year-over-year increase of 7289.80%, while its net profit experienced a year-over-year increase of 2500.29%.
Score
Financials
6.25
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
4.72
Operational Efficiency
2.92
Growth Potential
7.85
Shareholder Returns
6.45
Helius Medical Technologies Inc's Company Valuation
Currency: USD Updated: 2026-05-15The current valuation score of Helius Medical Technologies Inc is 8.01, ranking 48 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is 0.01, which is 255377.05% below the recent high of 15.58 and 21226.23% above the recent low of -1.29.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 147/206
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-15The current earnings forecast score of Helius Medical Technologies Inc is 6.00, ranking 175 out of 206 in the Healthcare Equipment & Supplies industry.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
3.500
Target Price
+52.17%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
75
Total
7
Median
7
Average
Company name
Ratings
Analysts
Helius Medical Technologies Inc
HSDT
2
Blackstone Inc
BX
24
KKR & Co Inc
KKR
22
BlackRock Inc
BLK
19
BROOKFIELD ASSET MANAGEMENT LTD
BAM
18
Ares Management Corp
ARES
17
1
2
3
...
15
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-15The current price momentum score of Helius Medical Technologies Inc is 1.68, ranking 204 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 2.49 and the support level at 2.02, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
2.246
Buy
MA10
2.214
Buy
MA20
2.146
Buy
MA50
2.067
Buy
MA100
2.337
Sell
MA200
5.217
Sell
Institutional Confidence
Currency: USD Updated: 2026-05-15Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-15The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Helius Medical Technologies Inc is 1.33, ranking 190 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.11. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. Helius Medical Technologies Inc’s latest ESG disclosure is at an average level in the Healthcare Equipment & Supplies industry, showing no material impact on overall risk.
Score
Beta vs S&P 500 index
1.12
VaR
+11.06%
240-Day Maximum Drawdown
+99.07%
240-Day Volatility
+262.41%
Return
Best Daily Return
60 days
+17.30%
120 days
+17.30%
5 years
+145.33%
Worst Daily Return
60 days
-11.37%
120 days
-13.56%
5 years
-65.14%
Sharpe Ratio
60 days
+1.07
120 days
-0.48
5 years
-0.93
Risk Assessment
Maximum Drawdown
240 days
+99.07%
3 years
+99.23%
5 years
+99.99%
Return-to-Drawdown Ratio
240 days
-1.00
3 years
-0.33
5 years
-0.20
Skewness
240 days
+4.23
3 years
+4.30
5 years
+5.24
Volatility
Realised Volatility
240 days
+262.41%
5 years
+262.73%
Standardised True Range
240 days
+92.69%
5 years
+3281.35%
Downside Risk-Adjusted Return
120 days
-96.79%
240 days
-96.79%
Maximum Daily Upside Volatility
60 days
+80.82%
Maximum Daily Downside Volatility
60 days
+61.35%
Liquidity
Average Turnover Rate
60 days
+2669.12%
120 days
+3350.03%
5 years
--
Turnover Deviation
20 days
-42.75%
60 days
-2.51%
120 days
+22.36%
Peer Comparison
Healthcare Equipment & Supplies
Helius Medical Technologies Inc
HSDT
4.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
